9 evolution "https:" "https:" "https:" "U.S" "St" positions at Université Claude Bernard Lyon 1 in France
Sort by
Refine Your Search
-
on the development of innovative contrast agents suitable for both CT and SPCCT. For this project, the advanced contrast agents will be evaluated for lung diseases imaging which are still challenging to diagnose and
-
volume. This method avoids tedious purification steps and uses very small amounts of protein and sample. This development therefore makes it possible to consider scaling up ligands using combinatorial
-
on the locomotor system – including musculoskeletal and motor control systems – through research focusing on locomotor development, function, and regeneration. MuSkLE-PhD offers 36-month fellowships within a 60
-
context is the development of new optoelectronic components based on the coupling of two separate components, one which addresses the electric current and a second which emits light locally, more precisely
-
monitor the photothermal expansion of the material due to molecular vibrations engendered by the infrared illumination. The development work will be focused on achieving higher temporal resolution with
-
. ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------...
-
. ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------...
-
. ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------...
-
. ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------...